1. Home
  2. BEAT vs SATX Comparison

BEAT vs SATX Comparison

Compare BEAT & SATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • SATX
  • Stock Information
  • Founded
  • BEAT 2015
  • SATX 2012
  • Country
  • BEAT United States
  • SATX Israel
  • Employees
  • BEAT N/A
  • SATX N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • SATX Radio And Television Broadcasting And Communications Equipment
  • Sector
  • BEAT Technology
  • SATX Technology
  • Exchange
  • BEAT Nasdaq
  • SATX Nasdaq
  • Market Cap
  • BEAT 59.8M
  • SATX 58.9M
  • IPO Year
  • BEAT 2021
  • SATX N/A
  • Fundamental
  • Price
  • BEAT $2.22
  • SATX $0.62
  • Analyst Decision
  • BEAT Buy
  • SATX
  • Analyst Count
  • BEAT 1
  • SATX 0
  • Target Price
  • BEAT $8.00
  • SATX N/A
  • AVG Volume (30 Days)
  • BEAT 78.6K
  • SATX 40.3K
  • Earning Date
  • BEAT 11-12-2024
  • SATX 11-03-2024
  • Dividend Yield
  • BEAT N/A
  • SATX N/A
  • EPS Growth
  • BEAT N/A
  • SATX N/A
  • EPS
  • BEAT N/A
  • SATX N/A
  • Revenue
  • BEAT N/A
  • SATX $11,112,000.00
  • Revenue This Year
  • BEAT N/A
  • SATX N/A
  • Revenue Next Year
  • BEAT N/A
  • SATX N/A
  • P/E Ratio
  • BEAT N/A
  • SATX N/A
  • Revenue Growth
  • BEAT N/A
  • SATX N/A
  • 52 Week Low
  • BEAT $1.06
  • SATX $0.30
  • 52 Week High
  • BEAT $3.39
  • SATX $0.80
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 49.47
  • SATX 34.27
  • Support Level
  • BEAT $2.06
  • SATX $0.61
  • Resistance Level
  • BEAT $2.30
  • SATX $0.65
  • Average True Range (ATR)
  • BEAT 0.13
  • SATX 0.04
  • MACD
  • BEAT 0.01
  • SATX -0.01
  • Stochastic Oscillator
  • BEAT 47.76
  • SATX 18.55

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About SATX SatixFy Communications Ltd.

SatixFy Communications Ltd develops end-to-end next-generation satellite communications systems, including satellite payloads, user terminals and modems, based on powerful chipsets that it develops in house. Its products include modems that feature Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the advanced communications standard DVB-S2X. Geographical presence in U.S, Canada, UK and Other countries. Majority of its company revenue comes from U.S and Canada.

Share on Social Networks: